BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/1/2014 5:04:00 PM | Browse: 1019 | Download: 1183
Publication Name World Journal of Gastroenterology
Manuscript ID 5949
Country Japan
Received
2013-09-28 22:08
Peer-Review Started
2013-09-30 09:28
To Make the First Decision
2013-10-14 21:05
Return for Revision
2013-10-17 11:23
Revised
2013-11-12 15:28
Second Decision
2014-01-15 20:22
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-01-15 20:39
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2014-02-28 13:47
Publish the Manuscript Online
2014-03-12 14:46
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Autobiography
Article Title Exenatide improves hepatic steatosis by enhancing lipid use in adipose tissue in nondiabetic rats
Manuscript Source Invited Manuscript
All Author List Kosuke Tanaka, Yuko Masaki, Masatake Tanaka, Masayuki Miyazaki, Munechika Enjoji, Makoto Nakamuta, Masaki Kato, Masatoshi Nomura, Toyoshi Inoguchi, Kazuhiro Kotoh and Ryoichi Takayanagi
Funding Agency and Grant Number
Corresponding Author Masaki Kato, MD, Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan. mkato11@intmed3.med.kyushu-u.ac.jp
Key Words Adipose tissue; Energy expenditure; Exenatide; Glucagon-like peptide-1; Hepatic steatosis; Lipolysis; Nonalcoholic fatty liver disease
Core Tip Glucagon-like peptide-1 (GLP-1) is reported to improve nonalcoholic fatty liver disease (NAFLD), mainly via direct action on the liver. However, organs other than the liver may also be involved in regulation of hepatic lipid contents. In this study, we found significant upregulation of lipolytic genes in adipose tissue in exenatide-treated NAFLD rats. Up-regulation of catalase, superoxide dismutase and mitochondrial morphological regulators was observed in adipose tissue. These metabolic changes were accompanied by increased oxygen consumption and decreased respiratory exchange ratio. Taken together, enhanced lipid use by GLP-1 in adipose tissue may play an important role in the improvement of NAFLD.
Publish Date 2014-03-12 14:46
Citation Tanaka K, Masaki Y, Tanaka M, Miyazaki M, Enjoji M, Nakamuta M, Kato M, Nomura M, Inoguchi T, Kotoh K, Takayanagi R. Exenatide improves hepatic steatosis by enhancing lipid use in adipose tissue in nondiabetic rats. World J Gastroenterol 2014; 20(10): 2653-2663
URL http://www.wjgnet.com/1007-9327/full/v20/i10/2653.htm
DOI http://dx.doi.org/10.3748/wjg.v20.i10.2653
Full Article (PDF) WJG-20-2653.pdf
Full Article (Word) WJG-20-2653.doc
Manuscript File 5949-Review.docx
Answering Reviewers 5949-Answering reviewers.pdf
Copyright License Agreement 5949-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate 5949-Language certificate.pdf
Peer-review Report 5949-Peer reviews.pdf
Scientific Editor Work List 5949-Scientific editor work list.doc